Bristol-Myers Squibb Company
BMY
$60.66
$0.360.60%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.50B | 12.22B | 12.27B | 11.20B | 12.34B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.50B | 12.22B | 12.27B | 11.20B | 12.34B |
| Cost of Revenue | 3.51B | 3.31B | 3.36B | 3.02B | 3.21B |
| Gross Profit | 9.00B | 8.91B | 8.91B | 8.18B | 9.13B |
| SG&A Expenses | 2.09B | 1.79B | 1.69B | 1.58B | 1.85B |
| Depreciation & Amortization | 826.00M | 831.00M | 830.00M | 830.00M | 1.69B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.98B | 8.36B | 8.14B | 7.67B | 9.55B |
| Operating Income | 3.52B | 3.86B | 4.13B | 3.54B | 2.80B |
| Income Before Tax | 1.47B | 3.11B | 1.77B | 2.97B | 175.00M |
| Income Tax Expenses | 384.00M | 919.00M | 460.00M | 509.00M | 99.00M |
| Earnings from Continuing Operations | 1.09B | 2.20B | 1.31B | 2.46B | 76.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.00M | 6.00M | -2.00M | -6.00M | -4.00M |
| Net Income | 1.09B | 2.20B | 1.31B | 2.46B | 72.00M |
| EBIT | 3.52B | 3.86B | 4.13B | 3.54B | 2.80B |
| EBITDA | 4.55B | 4.91B | 5.12B | 4.55B | 4.65B |
| EPS Basic | 0.53 | 1.08 | 0.64 | 1.21 | 0.04 |
| Normalized Basic EPS | 1.19 | 1.25 | 1.29 | 1.14 | 0.75 |
| EPS Diluted | 0.53 | 1.08 | 0.64 | 1.20 | 0.04 |
| Normalized Diluted EPS | 1.18 | 1.25 | 1.29 | 1.13 | 0.75 |
| Average Basic Shares Outstanding | 2.04B | 2.04B | 2.04B | 2.03B | 2.03B |
| Average Diluted Shares Outstanding | 2.04B | 2.04B | 2.04B | 2.04B | 2.04B |
| Dividend Per Share | 0.63 | 0.62 | 0.62 | 0.62 | 0.62 |
| Payout Ratio | 116.10% | 57.38% | 96.34% | 51.22% | 1,691.67% |